Cite
HARVARD Citation
Neelapu, S. et al. (n.d.). OUTCOMES OF PATIENTS ≥ 65 YEARS OF AGE IN ZUMA‐1, A PIVOTAL PHASE 1/2 STUDY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN REFRACTORY LARGE B CELL LYMPHOMA. Hematological oncology. pp. 303-304. [Online].